Invasive group A streptococcal infections in children with varicella in Southern California

Pediatric Infectious Disease Journal

Volumn 15, Issue 2, 1996, Pages 146-150

  Vugia, Duc J ^a   Peterson, Carol L ^b   Meyers, Hildy B ^c   Kim, Kwang Sik ^d   Arrieta, Antonio ^e   Schlievert, Patrick M ^f   Kaplan, Edward L ^f   Benson Werner, S ^a   Mascola, Laurene ^b  

^a Division of Communicable Disease Control   (United States)

^b U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^c Communic Dis Contr/Epidemiology County of Orange Health Care Agency ^*  (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Group A streptococcal infections; varicella

Indexed keywords

ARTICLE; CELLULITIS; CHICKENPOX; CHILD; CLINICAL ARTICLE; FEMALE; FEVER; HUMAN; INFANT; INFECTION CONTROL; INFECTION RISK; MALE; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; UNITED STATES;

EID: 0030051365     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199602000-00011     Document Type: Article

References (36)

1. Wharton M, Fehrs L, Cochi SL, Stroup N. Health impact of varicella in the 1980s [Abstract 1138A]. In: Program and Abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, GA, 1990.
2. Bullowa JGM, Wishik SM. Complications of varicella: I. Their occurrence among 2534 patients. Am J Dis Child 1935;49:923-6.
3. Fleisher G, Henry W, McSorley M, Arbeter A, Plotkin S. Life-threatening complications of varicella. Am J Dis Child 1981;135:896-9.
4. Rotta J, Tikhomirov E. Streptococcal diseases worldwide: present status and prospects. Bull WHO 1987;65:769-77.
5. Land MA, Bisno AL. Acute rheumatic fever: a vanishing disease in suburbia. JAMA 1983;249:895-8.
6. Wallace MR, Garst PD, Papadimos TJ, Oldfield EC III. The return of acute rheumatic fever in young adults. JAMA 1989;262:2557-61.
7. Centers for Disease Control. Group A beta-hemolytic streptococcalbacteremia: Colorado, 1989. MMWR 1990;39:3-6,11.
8. Communicable Disease Surveillance Center. Surveillance of, streptococcal infections: bacteremia and meningitis 1975-88. Communicable Dis ,Rep 1990;26:3-4.
9. Givner LB, Abramson JS, Wasilauskas B. Apparent increase in the incidence of invasive group A beta-hemolytic streptococcal disease in children. J Pediatr 1991;118:341-6.
10. Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome: a retrospective population-based study. JAMA 1993;269:384-9.
11. Cone LA, Woodard DR, Schlievert PM, Tomory GS. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med 1987;317:146-9.
12. Bartter T, Dascal A, Carroll K, Curley FJ. "Toxic strep syndrome": a manifestation of group A streptococcal infection. Arch Intern Med 1988;148:1421-4.
13. Stevens DL, Tanner MH, Winship J, et aL Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989;321:1-7.
14. Fischbacher CM, Green ST. Varicella and life-threatening streptococcal infection. Scand J Infect Dis 1987;19:519-20.
15. Christie CDC, Havens PL, Shapiro ED. Bacteremia with group A streptococci in childhood. Am J Dis Child 1988;142:559-61.
16. Wong VK, Wright HT Jr. Group A β-hemolytic streptococci as a cause of bacteremia in children. Am J Dis Child 1988;142:831-3.
17. Begovac J, Marton E, Lisic M, Beus I, Bozinovic D, Kusmanovic N. Group A beta-hemolytic streptococcal toxic shock-like syndrome. Pediatr Infect Dis J 1990;9:369-70.
18. Bradley JS, Schlievert PM, Sample TG Jr. Streptococcal toxic shock-like syndrome as a complication of varicella. Pediatr Infect Dis J 1991;10:77-9.
19. Gradon JD, Chapnick EK, Lutwick LI, Tepperberg J, Kahn M. Group A streptococcal meningitis complicating varicella. Pediatr Infect Dis J 1991;10:786-7.
20. Givner LB, Abramson JS, Wasilauskas B. Apparent increase in the incidence of invasive group A beta-hemolytic streptococcal disease in children. J Pediatr 1991;118:341-6.
21. Jackson MA, Burry VF, Olson LC. Complications of varicella requiring hospitalization in previously healthy children. Pediatr Infect Dis J 1992;11:441-5.
22. Novotny W, Faden H, Mosovich L. Emergence of invasive group A streptococcal disease among young children. Clin Pediatr 1992;31:596-601.
23. Leggiadro RJ, Bugnitz MC, Peck BA, et al. Group A streptococcal bacteremia in a Mid-South children's hospital. South Med J 1993;86:615-8.
24. Cohen-Abbo A, Harper MB. Case report: streptococcal toxic shock syndrome presenting as septic thrombophlebitis in a child with varicella. Pediatr Infect Dis J 1993;12:1033-4.
25. Davies HD, Matlow A, Scriver SR, et al. Apparent lower rates of streptococcal toxic shock syndrome and lower mortality in children with invasive group A streptococcal infections compared with adults. Pediatr Infect Dis J 1994;13:49-56.
26. Cowan MR, Primm PA, Scott SM, Abramo TJ, Wiebe RA. Serious group A beta-hemolytic streptococcal infections complicating varicella. Ann Emerg Med 1994;23:818-22.
27. Brogan TV, Nizet V, Waldhausen JHT, Rubens CE, Clarke WR. Group A streptococcal necrotizing fasciitis complicating primary varicella: a series of fourteen patients. Pediatr Infect Dis J 1995;14:588-94.
28. The Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition. JAMA 1993;269:390-1.
29. Swift NF, Wilson AT, Lancefield RC. Typing group A hemolytic streptococci by M precipitin reactions in capillary pipettes. J Exp Med 1943;78:127-33.
30. Hauser AR, Stevens DL, Kaplan EL, Schlievert PM. Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. J Clin Microbiol 1991;29:1562-7.
31. Brunell, PA. Varicella-zoster infections. In: Feigin RD, Cherry JD, eds. Textbook of pediatric infectious diseases. 3rd ed. Philadelphia: Saunders, 1992:1587-91.
32. Sudarsky LA, Laschinger JC, Coppa GF, Spencer FC. Improved results from a standardized approach in treating patients with necrotizing fasciitis. Ann Surg 1987;206:661-5.
33. Ward RG, Walsh MS. Necrotizing fasciitis: 10 years' experience in a district general hospital. Br J Surg 1991;78:488-9.
34. Bisno AL. Streptococcus pyogenes. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995:1786-99.
35. Stevens DL, Gibson AE, Bergstrom R, Winn V. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis 1988;158:23-8.
36. Schwartz B, Facklam RR, Breiman RF. Changing epidemiology of group A streptococcal infection in the USA. Lancet 1990;336:1167-71.